Jamie Brannan

Claire Fowler

After completing a degree in Veterinary Medicine at Cambridge University in 2002, her first professional experience was working in clinical veterinary practice before joining Boehringer Ingelheim in 2005. She subsequently completed an MBA at London Business School.

In Boehringer Ingelheim she has held positions at a local, regional and global level across business management, marketing and technical functions, mainly in Animal Health. This includes senior leadership roles such as the responsibility for the Boehringer Ingelheim Italian animal health subsidiary, and most recently for the overall commercial performance of the region encompassing Europe and Canada.  She also spent some time in Consumer Health Care as Category lead in global marketing.

Claire was appointed Head of Global Strategic Marketing in January 2025 and became a member of the Executive Committee of the Animal Health Business Unit at Boehringer.

Julia Loew

Linda Rhodes

Dr. Rhodes has over 30 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has an extensive background in physiology, veterinary medicine, and drug development, and many publications in peer-reviewed journals. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. As a senior research fellow at Merck Research Laboratories for 8 years, she led pre-clinical biology evaluation of several marketed human drugs. She worked for Merial Ltd. as director of large animal development projects, leading project teams developing novel compounds for a variety of indications. In April 2001, she formed AlcheraBio, a consulting, marketing, and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies world-wide. AlcheraBio was acquired in 2008 by Argenta, and Dr. Rhodes served as executive vice president to transition the company when in 2011, she accepted a position as CEO of Aratana Therapeutics, a startup company developing innovative new medicines for dogs and cats. Subsequently, when the company became public she served as its Chief Scientific Officer. During her 5-year tenure, the company achieved FDA approval of three new pet therapeutics: Galliprant, Nocita and Entyce. She is currently retired and an independent consultant. She is a member of the Board of Directors of Zoetis, and serves on the Scientific Advisory Boards of the Alliance for Contraception in Dogs and Cats and the Michelson Found Animals Foundation. She founded Feather in Her Cap, a non-profit that recognizes the achievement of women in the animal health industry. She is the recipient of the Iron Paw Award.

Aaron Schacht

Thomas Zerzan